Literature DB >> 7898603

Risk factors for primary cerebral hemorrhage: a population-based study--the Stroke Registry of Dijon.

M Giroud1, E Creisson, H Fayolle, N André, F Becker, D Martin, R Dumas.   

Abstract

Risk factors for primary cerebral hemorrhage remain uncertain. The population-based Stroke Registry of Dijon provides data on the risk factors. Among residents of Dijon (France), 130 cases of primary cerebral hemorrhage hospitalized from 1985 to 1992 were matched with 130 controls by age and sex. The following data were collected: history of hypertension, alcohol consumption, tobacco consumption, history of coagulation disorder, diabetes mellitus, dyslipidemia, and infectious disease in the 7 days before admission. The following parameters were measured on admission: blood pressure, blood glucose, cholesterol, triglycerides, hematocrit, fibrinogen, prothrombin levels, platelet counts, prothrombin time, bilirubin, transaminases, gamma-glutamyltransferase, and alkaline phosphatase. Electrocardiogram and Doppler ultrasound examination of cervical arteries were performed. Statistical analysis was performed by means of relative risk ratio for paired samples when dealing with proportions, and Student's t test for quantitative variables. A stepwise discriminant analysis was carried out to establish the relative weight of the different risk factors and their discriminant values. Among the qualitative data, the significant factors were history of hypertension, alcohol consumption, cardiac arrhythmia, atherosclerosis of carotid arteries and a previous infectious disease in the 7 days before admission. Among the quantitative data, the significant factors were early hypertension, high blood glucose levels, high hematocrit, and low cholesterol levels, in the acute stage of the stroke. After multifactorial analysis, only two factors were significant: hypertension and low cholesterol levels. Our population-based case-control study showed that hypertension and low cholesterol levels are the two discriminant risk factors for both lobar and basal ganglia primary cerebral hemorrhage. Therefore, treatment of hypercholesterolemia may increase risk of cerebral hemorrhage.

Entities:  

Mesh:

Year:  1995        PMID: 7898603     DOI: 10.1159/000109775

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  6 in total

1.  Combined therapy of intensive statin plus intravenous rt-PA in acute ischemic stroke: the INSPIRE randomized clinical trial.

Authors:  Wan-Yong Yang; Yu-Feng Li; Zi-Ran Wang; Tian-Xia Yu; Dong-Juan Xu; Nan Yang; Xiao-Yuan Niu; Xue-Li Cai; Wen-Yan Zhuo; Xue-Mei Wu; Min Yan; Jun-Shan Zhou; Hao-Wen Zhang; Zhi-Gang Liang; Wen-Jun Wu; Jian-Hua Cheng; Li-An Huang; Yu-Sheng Zhang; Ying Guan; Ze-Feng Tan; Dan Lu; Niu He; Da-Wei Dong; Hui-Li Zhu; Bing Yang; Qing-Yu Shen; An-Ding Xu
Journal:  J Neurol       Date:  2021-02-08       Impact factor: 4.849

2.  Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case-control study and a meta-analysis.

Authors:  Sergi Martinez-Ramirez; Raquel Delgado-Mederos; Rebeca Marín; Marc Suárez-Calvet; María Pilar Sáinz; Aída Alejaldre; Ángela Vidal-Jordana; Josep Lluís Martí-Vilalta; Joan Martí-Fàbregas
Journal:  J Neurol       Date:  2011-06-18       Impact factor: 4.849

3.  Association between diabetes mellitus and the occurrence and outcome of intracerebral hemorrhage.

Authors:  Marion Boulanger; Michael T C Poon; Sarah H Wild; Rustam Al-Shahi Salman
Journal:  Neurology       Date:  2016-07-29       Impact factor: 9.910

4.  Risk factors for primary intracerebral hemorrhage in patients in Izumo City, Japan.

Authors:  Tetsuji Inagawa
Journal:  Neurosurg Rev       Date:  2007-05-15       Impact factor: 2.800

5.  Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: a Danish population-based case-control study.

Authors:  Henning Grønbaek; Søren P Johnsen; Peter Jepsen; Mette Gislum; Hendrik Vilstrup; Ulrik Tage-Jensen; Henrik T Sørensen
Journal:  BMC Gastroenterol       Date:  2008-05-24       Impact factor: 3.067

6.  Noncommunicable diseases: current status of major modifiable risk factors in Korea.

Authors:  Hyeon Chang Kim; Sun Min Oh
Journal:  J Prev Med Public Health       Date:  2013-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.